Gene transfer into hematopoietic cells

Area of Science:

• * Molecular Biology
• * Gene Therapy
• * Stem Cell Biology

Background:

• * Efficient gene transfer into stem cells is crucial for developing novel therapeutics.
• * Retroviral vectors show limitations in gene insertion into stem cells of larger animals and humans due to stem cell quiescence.
• * Alternative vector systems are needed to overcome these barriers in stem cell gene therapy.

Purpose of the Study:

• * To investigate the potential of recombinant adeno-associated virus (AAV) vectors for gene transfer into quiescent stem cells.
• * To evaluate the expression and integration of a globin gene using AAV vectors in human erythroid cells.
• * To assess the stability and expression levels of the integrated globin gene.

Main Methods:

• * Utilized recombinant adeno-associated virus (AAV) vectors for gene transfer.
• * Transduced human erythroid cells with a globin gene linked to its regulatory elements.
• * Analyzed gene integration, expression, and stability at high multiplicities of infection.

Main Results:

• * Recombinant AAV vectors successfully transferred, expressed, and integrated a globin gene into human erythroid cells.
• * Gene insertion and expression were achieved despite the quiescent state of the cells.
• * The integrated globin gene demonstrated stable expression at levels comparable to endogenous globin genes.

Conclusions:

• * Recombinant adeno-associated virus (AAV) vectors show promise for gene transfer into quiescent stem cells, including human erythroid cells.
• * AAV vectors can mediate stable integration and expression of therapeutic genes, offering a potential alternative to retroviral vectors.
• * This approach holds significant potential for advancing stem cell-based gene therapies.